Abstract
Being naturally enriched in key nutrients and in various health-promoting compounds, seaweeds represent promising candidates for the design of functional foods. Soluble dietary fibers, peptides, phlorotannins, lipids and minerals are macroalgae’s major compounds that can hold potential in high-value food products derived from macroalgae, including those directed to the cardiovascular-health promotion. This manuscript revises available reported data focusing the role of diet supplementation of macroalgae, or extracts enriched in bioactive compounds from macroalgae origin, in targeting modifiable markers of cardiovascular diseases (CVDs), like dyslipidemia, oxidative stress, vascular inflammation, hypertension, hypercoagulability and activation of the sympathetic and renin-angiotensin systems, among others. At last, the review also describes several products that have been formulated with the use of whole macroalgae or extracts, along with their claimed cardiovascular-associated benefits.
Subject
Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science
Reference141 articles.
1. Cardiovascular Diseases (CVDs)http://www.who.int/mediacentre/factsheets/fs317/en/
2. Cardiovascular Diseaseshttp://www.who.int/cardiovascular_diseases/about_cvd/en/
3. Cardiovascular Disease Risk Factorshttp://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/
4. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
5. Dyslipidemia in Obesity: Mechanisms and Potential Targets
Cited by
137 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献